跳至主要内容
临床试验/NCT00118716
NCT00118716已完成4 期

A Stratified, Multicenter, Randomized, Double-Blind, Parallel Group, 4-Week Comparison of Fluticasone Propionate/Salmeterol DISKUS Combination Product 100/50mcg BID Versus Fluticasone Propionate DISKUS 100mcg BID in Pediatric and Adolescent Subjects With Activity-Induced Bronchospasm

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 248 人开始时间: 2003年12月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
248
试验地点
1
主要终点
Maximal Percent Change in Forced Expiratory Volume in 1 Second (FEV1) Following Exercise Challenge at Week 4

研究概览

简要总结

During this study, your child will need to attend up to 5 office visits and maintain regular telephone contact with the clinic. Certain office visits will include physical exams, medical history review, exercise challenge test (walking/running on a treadmill), electrocardiogram (ECG) tests, and lung function tests. All study related medications and medical examinations are provided at no cost. All study drugs are currently available by prescription to patients 4 years and older.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment

入排标准

年龄范围
4 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

FSC 100/50 mcg BID

Experimental

Participants received FSC 100/50 microgram (mcg) one inhalation as a combination product via DISKUS, twice daily in morning after awakening and in evening for up to 28 days

干预措施: Fluticasone propionate/salmeterol (Drug)

FP 100 mcg BID

Experimental

Participants received FP 100 mcg one inhalation via DISKUS, twice daily in morning after awakening and in evening for up to 28 days.

干预措施: Fluticasone Propionate (Drug)

结局指标

主要结局

Maximal Percent Change in Forced Expiratory Volume in 1 Second (FEV1) Following Exercise Challenge at Week 4

时间窗: Baseline and Week 4

FEV1 is a measure of lung function and is defined as the maximal amount of air that can be forcefully exhaled in one second. Maximal percent change in FEV1 following exercise challenge was defined as the percent change from pre-exercise baseline FEV1 to the minimum FEV1 collected within one hour following exercise challenge. Maximal percent change in FEV1 following exercise challenge was mean maximal percent change from pre-exercise baseline compared between treatment groups at Treatment Week 4. FEV1 was measured 5, 10, 15, 30, and 60 minutes post-exercise. The minimum FEV1 measured across these time points, regardless of any missing time points, will be used for the calculation of maximal percent change.

次要结局

  • Change From Baseline in Evening (PM) PEF(Baseline and up to Week 4)
  • Four-hour Serial Post-dose FEV1 Area Under the Curve (AUC) on Treatment Day 1(Immediately prior to dosing (0 time point), 30 minutes post-dose and 1, 2, 3, 4 hour post-dose on Day 1)
  • Change From Baseline in Morning Peak Expiratory Flow (AM PEF)(Baseline and Up to Week 4)
  • Percent of Rescue-free Days(Up to Week 4)
  • Percent of Symptom-free Days(Up to Week 4)
  • Change From Baseline in Pediatric Asthma Quality of Life Questionnaire (PAQLQ)(Baseline (Week 0) and up to Week 4)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验